$HUM News

HUM Q2 Deep Dive: Margin Initiatives, Operational Progress, and Medicare Advantage Strategy

US Insurer Humana Is Exiting More Medicare Advantage Plans in 2027— Here's Who Could Be Affected

TD Cowen Maintains Hold on Humana, Raises Price Target to $370

Barclays Maintains Equal-Weight on Humana, Raises Price Target to $407

Raymond James Downgrades Humana (HUM)

Evercore ISI Group Upgrades Humana (HUM)

UBS Maintains Neutral on Humana, Raises Price Target to $405

Humana (HUM) Stock Trades Down, Here Is Why

Evercore ISI Group Upgrades Humana to Outperform, Raises Price Target to $480

Guggenheim Maintains Buy on Humana, Raises Price Target to $471

US Insurer Humana Is Exiting More Medicare Advantage Plans in 2027— Here's Who Could Be Affected

Raymond James Downgrades Humana to Market Perform

Humana Inc (HUM) Q2 2026 Earnings Call Highlights: Strategic Exits and Margin Expansion Plans

Humana Q2 Earnings Review: Management Tight-Lipped, But Recovery Still On Track

S&P 500 Stocks: GEHC Revives, Humana Fades On Earnings

Compared to Estimates, Humana (HUM) Q2 Earnings: A Look at Key Metrics

Humana (HUM) Stock Looks Fairly Valued Despite Its 70% Run

Humana Shares Fall Despite Second-Quarter Earnings Beat and Reaffirmed Outlook

Humana (NYSE:HUM) Exceeds Q2 CY2026 Expectations

Humana (HUM) Q2 Earnings and Revenues Top Estimates